Effects of Insulin against Aluminium Induced Neurotoxicity in Wistar Rats

Amir Alam, Garima Bansal

Abstract


Aluminium toxicity is well known to cause neurotoxicity leading to Alzheimer disease with dementia. The aim of the present study is to evaluate the effects of Insulin in Aluminium induced neurotoxicity. Thirty male wistar rats randomized into three groups (group V, C, T) of ten each were used for the study after obtaining institutional animal ethics committee approval. Chronic aluminium neurotoxicity was induced in the rats and the neurobehavior was evaluated using Morris water maze test, elevated plus maze test and rotarod test using standard methodologies. Group C rats exhibited significant deviation in performance of behavioural test of the study during day 1 (Morris water maze test- 18.6±9.5, elevated plus maze test- 34.9±1.9, rotarod test- 118.6±15.2) and day 30 (Morris water maze test- 64.5±4.6, elevated plus maze test- 72.1±3.9, rotarod test- 110.7±9.3). Rats of group T showed decrease in behavioural changes induced by aluminium toxicity (P value: Morris water maze test-0.0002, elevated plus maze test- 0.0007 and rotarod test- 0.015). Insulin may play a role in neuroprotection against toxicity similar to that of aluminium induced neurotoxicity.


Keywords


Neurotoxicity; Aluminium; Insulin; Chronic; Neurobehaviour

Full Text:

PDF

References


Zatta PF. Biological models for the study of aluminium neurotoxicity. ACTA MEDICA ROMANA. 1997;35:592-600.

Ghanta M, Panchanathan E, Lakkakula BV, Narayanaswamy A. Retrospection on the role of soluble guanylate cyclase in parkinson's disease. Journal of pharmacology & pharmacotherapeutics. 2017;8(3):87.

Klatzo I, WISNIEWSKI H, Streicher E. Experimental production of neurofibrillary degeneration: 1. Light microscopic observations. Journal of neuropathology and experimental neurology. 1965;24(2):187-99.

Platt B, Haas H, Büsselberg D. Aluminium reduces glutamate-activated currents of rat hippocampal neurones. Neuroreport. 1994;5(17):2329-32.

Ghanta M, Panchanathan E, Lakkakula BV, Narayanaswamy A, Abhinand PA, Antony S. Molecular docking analysis of phytoconstituent from Momordica charantia with Guanylate Cyclase catalytic domain. Bioinformation. 2018;14(7):378.

Meiri H, Banin E, Roll M, Rousseau A. Toxic effects of aluminium on nerve cells and synaptic transmission. Progress in neurobiology. 1993;40(1):89-121.

Cain DP. Testing the NMDA, long-term potentiation, and cholinergic hypotheses of spatial learning. Neuroscience & Biobehavioral Reviews. 1998;22(2):181-93.

Suárez-Fernández MB, Soldado AB, Sanz-Medel A, Vega JA, Novelli A, Fernández-Sánchez MT. Aluminum-induced degeneration of astrocytes occurs via apoptosis and results in neuronal death. Brain research. 1999;835(2):125-36.

Bondy SC, Truong A. Potentiation of beta-folding of β-amyloid peptide 25–35 by aluminum salts. Neuroscience letters. 1999;267(1):25-8.

Troncoso JC, Sternberger NH, Sternberger LA, Hoffman PN, Price DL. Immunocytochemical studies of neurofilament antigens in the neurofibrillary pathology induced by aluminum. Brain research. 1986;364(2):295-300.

Drewes G, Ebneth A, Mandelkow EM. MAPs, MARKs and microtubule dynamics. Trends in biochemical sciences. 1998;23(8):307-11.

Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 1982;215(4537):1237-9.

Holzer M, Holzapfel HP, Zedlick D, Brückner MK, Arendt T. Abnormally phosphorylated tau protein in Alzheimer's disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience. 1994;63(2):499-516.

Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 1996;274(5284):99-103.

Grutzendler J, Morris JC. Cholinesterase inhibitors for Alzheimer’s disease. Drugs. 2001;61(1):41-52.

Emre M. Switching cholinesterase inhibitors in patients with Alzheimer's disease. International journal of clinical practice. Supplement. 2002;127:64-72.

Ogasawara Y, Sakamoto T, Ishii K, Takahashi H, Tanabe S. Effects of the administration routes and chemical forms of aluminum on aluminum accumulation in rat brain. Biological trace element research. 2002;86(3):269-78.

Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. Journal of neuroscience methods. 1984;11(1):47-60.

Pellow S, Chopin P, File SE, Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of neuroscience methods. 1985;14(3):149-67.

Dunham NW, Miya TS. A note on a simple apparatus for detecting neurological deficit in rats and mice. Journal of the American Pharmaceutical Association. 1957;46(3):208-9.

Valzelli L, Essman WB. Psychopharmacology: An introduction to experimental and clinical principles. Spectrum Publ.; 1973.

Tilson HA. Harry GJ. Behavioral principles for use in behavioural toxicology and pharmacology. In: Nervous system toxicology. Editor. C. Mitchell. Raven Press. NewYork. 1982:1-27.

Mello NK. Behavioral toxicology: a developing discipline. In Behavioral Pharmacology. Boston: Springer; 1975.

Platt B, Fiddler G, Riedel G, Henderson Z. Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain research bulletin. 2001;55(2):257-67.

Roloff EV, Platt B, Riedel G. Long-term study of chronic oral aluminum exposure and spatial working memory in rats. Behavioral neuroscience. 2002;116(2):351.

Watson GS, Craft S. Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. European journal of pharmacology. 2004;490(1-3):97-113.

Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm HL, Born J et al. Intranasal insulin improves memory in humans. Psychoneuroendocrinology. 2004;29(10):1326-34.

Carro E, Torres-Aleman I. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease. European journal of pharmacology. 2004;490(1-3):127-33.

Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O'brien PC et al. Risk of dementia among persons with diabetes mellitus: a population-based cohort study. American journal of epidemiology. 1997;145(4):301-8.

Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MM. Association of diabetes mellitus and dementia: the Rotterdam Study. Diabetologia. 1996;39(11):1392-7.

Malhotra S, Kondal A, Shafiq N, Sidhu S, Bhasin DK, Pandhi P. A comparison of observational studies and controlled trials of heparin in ulcerative colitis. International journal of clinical pharmacology and therapeutics. 2004;42(12):690-4.

Chen Y, Deng Y, Zhang B, Gong CX. Deregulation of brain insulin signaling in Alzheimer’s disease. Neuroscience bulletin. 2014;30(2):282-94.

Iwamoto T, Ouchi Y. Emerging evidence of insulin-like growth factor 2 as a memory enhancer: a unique animal model of cognitive dysfunction with impaired adult neurogenesis. Reviews in the Neurosciences. 2014;25(4):559-74.




DOI: https://doi.org/10.15416/pcpr.v5i2.28096

Refbacks

  • There are currently no refbacks.


                                                                         
Pharmacology and Clinical Pharmacy Research is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
 
                                                                      VIEW VISITOR STATS